February 05, 2021

Bond v. Clover Health Investments, Corp. et al

View recent docket activity


Reflects complaints, answers, motions, orders and trial notes entered from Jan. 1, 2011.
Additional or older documents may be available in Pacer.


Coverage

  1. October 03, 2023

    Pomerantz Plucks $5.5M Fee For Clover Health Investor Deal

    A legal team headed up by Pomerantz LLP will receive a $5.5 million fee for its work representing investors in Medicare Advantage insurance provider Clover Health Investments Corp., alleging the company concealed a U.S. Department of Justice investigation it faced in the lead-up to its go-public merger with a special purpose acquisition company.

4 other articles on this case. View all »

Parties

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Direct access to case information and documents.
  • All significant new filings across U.S. federal district courts, updated hourly on business days.
  • Full-text searches on all patent complaints in federal courts.
  • No-fee downloads of the complaints and so much more!

TRY LAW360 FREE FOR SEVEN DAYS